UB Paderborn / Katalog / Suche / in CDI

A phase I/II study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B

The Journal of clinical investigation, 2023-01, Vol.133 (2), p.1-13

2023

Volltextzugriff (PDF)

CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals

Annual review of biochemistry, 1999-01, Vol.68 (1), p.821-861

1999

Volltextzugriff (PDF)

Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial

Clinical therapeutics, 2015-05, Vol.37 (5), p.1012-1021.e6

2015

Volltextzugriff (PDF)

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III

Orphanet journal of rare diseases, 2017-06, Vol.12 (1), p.117-117, Article 117

2017

Volltextzugriff (PDF)

Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration

Pediatric neurology, 2017-02, Vol.67, p.23-35

2017

Volltextzugriff (PDF)

CREB Transcriptional Activity in Neurons Is Regulated by Multiple, Calcium-Specific Phosphorylation Events

Neuron (Cambridge, Mass.), 2002-04, Vol.34 (2), p.221-233

2002

Volltextzugriff (PDF)

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels: Results From 2 Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Phase 1 Studies in Healthy Volunteers and Hypercholesterolemic Subjects on Statins

Journal of the American College of Cardiology, 2012-11, Vol.60 (19), p.1888-1898

2012

Volltextzugriff (PDF)

Best practices for the use of intracerebroventricular drug delivery devices

Molecular genetics and metabolism, 2018-07, Vol.124 (3), p.184-188

2018

Volltextzugriff (PDF)

Hypocalcaemia in patients with metastatic bone disease treated with denosumab

European journal of cancer (1990), 2015-09, Vol.51 (13), p.1812-1821

2015

Volltextzugriff (PDF)

Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders

Molecular therapy, 2022-07, Vol.30 (7), p.2416-2428

2022

Volltextzugriff (PDF)

Longitudinal Natural History of Pediatric Subjects Affected with Mucopolysaccharidosis IIIB

The Journal of pediatrics, 2022-10, Vol.249, p.50-58.e2

2022

Volltextzugriff (PDF)

Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y

Pediatric research, 2015-12, Vol.78 (6), p.717-722

2015

Volltextzugriff (PDF)

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels

Journal of the American College of Cardiology, 2012-11, Vol.60 (19), p.1888-1898

2012

Volltextzugriff (PDF)

Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome

Molecular genetics and metabolism, 2016-09, Vol.119 (1-2), p.131-143

2016

Volltextzugriff (PDF)

Calcium Regulation of Neuronal Gene Expression

Proceedings of the National Academy of Sciences - PNAS, 2001-09, Vol.98 (20), p.11024-11031

2001

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients with Morquio A Syndrome

Clinical pharmacokinetics, 2014-12, Vol.53 (12), p.1137-1147

2014

Volltextzugriff (PDF)

Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism

Neuron (Cambridge, Mass.), 1998-04, Vol.20 (4), p.709-726

1998

Volltextzugriff (PDF)

Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot study

American journal of medical genetics. Part A, 2015-10, Vol.167A (10), p.2272-2281

2015

Volltextzugriff (PDF)

Grizzly bears exhibit augmented insulin sensitivity while obese prior to a reversible insulin resistance during hibernation

Cell metabolism, 2014-08, Vol.20 (2), p.376-382

2014

Volltextzugriff (PDF)

PI3K Enters Beta-Testing

Cell metabolism, 2008-09, Vol.8 (3), p.179-181

2008

Volltextzugriff (PDF)

Magnitude of the CREB-Dependent Transcriptional Response Is Determined by the Strength of the Interaction between the Kinase-Inducible Domain of CREB and the KIX Domain of CREB-Binding Protein

Molecular and Cellular Biology, 2000-12, Vol.20 (24), p.9409-9422

2000

Volltextzugriff (PDF)

Design and rationale of the study programs for BMN 250, a novel enzyme replacement therapy (ERT) for Sanfilippo syndrome type B

Molecular genetics and metabolism, 2016-02, Vol.117 (2), p.S105-S106

2016

Volltextzugriff (PDF)

AMG 145, a Fully Human Monoclonal Antibody Against PCSK9, Reduces LDL-C in Healthy Volunteers and Patients on Stable Doses of Statins

Journal of clinical lipidology, 2012-05, Vol.6 (3), p.286-287

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A phase I/II study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B

CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals

Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III

Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration

CREB Transcriptional Activity in Neurons Is Regulated by Multiple, Calcium-Specific Phosphorylation Events

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels: Results From 2 Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Phase 1 Studies in Healthy Volunteers and Hypercholesterolemic Subjects on Statins

Best practices for the use of intracerebroventricular drug delivery devices

Hypocalcaemia in patients with metastatic bone disease treated with denosumab

Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders

Longitudinal Natural History of Pediatric Subjects Affected with Mucopolysaccharidosis IIIB

Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels

Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome

Calcium Regulation of Neuronal Gene Expression

Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients with Morquio A Syndrome

Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism

Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot study

Grizzly bears exhibit augmented insulin sensitivity while obese prior to a reversible insulin resistance during hibernation

Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type B

PI3K Enters Beta-Testing

Cardiopulmonary Exercise Testing Reflects Improved Exercise Capacity in Response to Treatment in Morquio A Patients: Results of a 52-Week Pilot Study of Two Different Doses of Elosulfase Alfa

Magnitude of the CREB-Dependent Transcriptional Response Is Determined by the Strength of the Interaction between the Kinase-Inducible Domain of CREB and the KIX Domain of CREB-Binding Protein

Design and rationale of the study programs for BMN 250, a novel enzyme replacement therapy (ERT) for Sanfilippo syndrome type B

AMG 145, a Fully Human Monoclonal Antibody Against PCSK9, Reduces LDL-C in Healthy Volunteers and Patients on Stable Doses of Statins

Suchergebnisse filtern